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A high-quality human reference panel reveals the
complexity and distribution of genomic structural
variants
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Ommen15, P. Eline Slagboom19, Dorret I. Boomsma9, Alexander Scho¨nhuth8, Kai Ye20,21,22, Victor Guryev11
Structural variation (SV) represents a major source of differences between individual human
genomes and has been linked to disease phenotypes. However, the majority of studies pro-
vide neither a global view of the full spectrum of these variants nor integrate them into
reference panels of genetic variation. Here, we analyse whole genome sequencing data of 769
individuals from 250 Dutch families, and provide a haplotype-resolved map of 1.9 million
genome variants across 9 different variant classes, including novel forms of complex indels,
and retrotransposition-mediated insertions of mobile elements and processed RNAs. A large
proportion are previously under reported variants sized between 21 and 100 bp. We detect 4
megabases of novel sequence, encoding 11 new transcripts. Finally, we show 191 known, trait-
associated SNPs to be in strong linkage disequilibrium with SVs and demonstrate that our
panel facilitates accurate imputation of SVs in unrelated individuals.
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C
omprehensive catalogues of genetic variation are
fundamental building blocks in studies of population
and demographic history, variant formation and
genotype-phenotype association. To obtain insights in ancestry
and linkage disequilibrium of polymorphic sites it is imperative
that such catalogues are haplotype-resolved (phased). Crucial
improvements in accuracy and power can be achieved through
population-specific panels1,2. However, current reference panels
contain single nucleotide polymorphisms (SNPs), insertions and
deletions of up to 20 bp in length (indels) but only a very limited
number of structural variants (SVs) larger than 50 bp in size3,4.
There is ample evidence that SV’s play a major role in evolution
and disease5–9. Therefore, despite posing substantial technical
and methodological challenges with respect to discovery,
genotyping and phasing of such SV variants, the integration of
SVs into reference panels is crucial for a broad spectrum of
studies10,11.
Recently several population-scale sequencing projects have
been undertaken aimed at capturing global genetic diversity12–15.
In addition, a number of projects have focused on single
populations attempting to capture the genetic variability of
sociologically and/or historically coherent groups of people for
specific variant types15–18. For example the UK10K project, which
aims at capturing rare variants, comprising SNPs, indels and large
deletions used B7 whole-genome and B80 whole-exome
sequencing of nearly 10,000 individuals17. A similar subset of
variant types were included in the Malay and the Danish genome
sequencing projects which both used high coverage (30 –50 ),
focusing on rare variants that characterize the population18,
de novo variants and the assembly of novel sequence16.
One of the primary goals of the Genome of the Netherlands
(GoNL) project1,19 was to characterize whole-genome variation
in the Dutch population. Our initial reports focused on a
whole-genome catalogue of SNVs, small insertions/deletions, and
unphased SV deletion events20,21. Here, we focus on discovery,
genotyping and phasing the full spectrum of structural variants to
generate a high-quality SV-integrated, haplotype-resolved
reference panel by exploiting two key features of the GoNL
project design. First, sufficient coverage (14.5 median base
coverage, 38.4 median physical coverage) allows for enhanced
genotyping including SVs, as was recently described18,22,23.
Second, the 769 GoNL individuals originate from parent-
offspring families (231 trios and 19 families in which twin pairs
are included in the offspring generation), yielding family-based
high-quality haplotypes across substantially longer ranges
in comparison to statistically phased unrelated individuals24,25.
In addition to create a haplotype resolved panel, we report
several currently under reported variant types, such as deletions
21–100 bp in size, complex indels, inversions, mobile element
insertions (MEIs), large replacements and insertions of new
genomic sequence26.
Results
Detection of structural variation. We analysed Illumina whole
genome sequencing data derived from 250 parent-offspring
families (769 individuals) from the Dutch population to detect
structural variants and indels (non-SNVs) using 12 different
variant detection tools representing 4 algorithmic approaches
(gapped alignment and split-read mapping, discordant read
pair, read depth and de novo genome assembly), Fig. 1a,
Supplementary Table 1. The results from the different detection
tools were combined into a consensus set containing 9 different
forms of SVs and indels (simple indels, complex indels, deletions,
duplications, inversions, MEIs, interchromosomal breakpoints,
novel segments and large replacements). Compared with multiple
public data resources1,14,26–28, 13.6% of all (simple and complex)
indels and 38% of SVs we report are novel (Table 1). To show the
specificity of our structural variant predictions, we selected a
representative set of candidates across all 9 variant types and
performed an independent experimental validation using
PCR-amplification across the variant breakpoints followed by
Sanger or Illumina MiSeq sequencing (Supplementary Data 1).
This yielded a confirmation rate for each variant class of between
80 and 98.6% with the exception of inversions (64.5%), which
failed to produce a PCR product in 35.5% of the cases (Table 1).
The high rate of PCR failures for inversions might either be a
result of false positives, or stem from poor performance of PCR
assays, given the frequent occurrence of repetitive and complex
sequences at inversion breakpoints.
Deletions and insertions. We first focused our analysis on
deletions and insertions of DNA sequence relative to the
reference assembly. This revealed 646,011 short insertions
(1–20 bp), 1,093,289 short deletions (1–20 bp), 24,167 mid-sized
deletions (21–100 bp) and 19,840 larger deletions (101 bp–
1,467 kb) of which the majority (99,8%) could be genotyped
(Table 1, Fig. 1b). We observed an increased number of
deletions with size ranges corresponding to SINE and LINE
retrotransposition events (Fig. 2, Supplementary Fig. 1).
A substantial fraction of the simple indels (11.5%), mid-sized
deletions (21.6%) and 41.9% of larger deletions were novel. Of the
previously known mid-sized deletions, 79.2% were present solely
in our previous GoNL release and in no other call set, empha-
sizing that this size class has been previously under-investigated.
The consensus set of deletion events were found to be
significantly depleted in exonic regions (Po10 4) and UTRs
(Po10 4), as well as known disease terms from Online
Mendelian Inheritance in Man (OMIM) database, and deletions
predicted to result in a loss of function when compared with
10,000 random sets of size matched variants (Po10 4). Further
analyses showed that 11 deletions were in transmission
disequilibrium (Supplementary Table 2).
Duplications. We identified 1,738 tandem duplications, 34.6% of
which could be successfully genotyped. This low percentage is
likely due to the limitations of current computational methods.
The majority of the events were novel (84%, n¼ 1,458) and
contained repeat elements such as simple repeats (n¼ 914) or
segmental duplication (n¼ 194). A minority of the duplication
events (n¼ 88) overlapped a RefSeq gene of which 71 affected
at least one exon within a gene and 41 events overlapped at least
one exon of a gene with an OMIM disease entry (including
susceptibility loci and recessive disease genes) (Table 1,
Supplementary Fig. 2).
Complex structural variation. A significant proportion of
structural variants cannot be described as simple events. Our data
show that a sizeable fraction of indels (3%, n¼ 52,913) represent
cases where one multibase segment of DNA (2–10 bp) is replaced
by another sequence of different lengths (1–11 bp), of which only
a minority (17.2%) has previously been described. Furthermore,
by combining calls from discordant pair analysis with de novo
genome assembly we were able to detect 84 inversions and 60
interchromosomal events, of which 69 and 46 could be
successfully genotyped. Interestingly, most of these variants
were common with average allele frequencies of 22.8% and
32.2%, respectively. Manual curation of interchromosomal
events showed that the majority possessed a polyA stretch at
the interchromosomal breakpoints and therefore was likely to
originate from retrotransposition events. This observation was
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Figure 1 | Overviews of discovery approach and variant set. (a) Overview of methods used for SV detection, genotyping and phasing within the GoNL
project. (b) Structural variation consensus set, consisting of large duplications (outer ring), deletions larger than 100 bp (light red), chromosomes,
insertions (triangles), mid-sized deletions (21–100bp), small deletions (less than 20 bp) (dark red) and complex indels (purple). Heatmaps display the
insertions of Alu, L1 and SVA elements. Inversions are indicated by black arcs in the centre of the plot, and interchromosomal break points (colored based
on the source chromosome).
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supported by our orthogonal validations, which showed that 11 of
the interchromosomal events contained processed parts of known
transcripts and were further characterized as gene retrocopy
insertion polymorphisms29 (GRIP) (Supplementary Data 2).
Mobile element insertions. MEIs are a common type of
retrotransposition-mediated insertions. In total we identified
13,469 MEIs, making it a frequent form of structural variation
(23% of SVs larger than 20 bp). The majority of MEIs could
be genotyped (99.7%, n¼ 13,430) and were novel (56%) in
comparison to those previously reported (Table 1). Non-reference
insertions of Alu (n¼ 8,670) were the most common form of
event followed by L1 (n¼ 4,011), SVA (n¼ 781) and HERV
(n¼ 7) insertions. The majority of MEI elements (n¼ 8,136) were
located in intergenic regions (Supplementary Fig. 2); however 49
events were predicted to occur within exonic regions, including
validated AluYa4/5 insertions into coding sequences of OPRM1,
METTL4 and ARHGAP28, as well as a heterozygous AluYk12
insertion into the last exon of the EYS gene, a gene which is
involved in autosomal recessive retinitis pigmentosa30
(Supplementary Fig. 3). The insertion in ARHGAP28 was
observed in three families, while each of the other three coding
MEIs were family-specific events. This suggests that these MEIs in
the coding part of the genome are relatively recent and/or
deleterious.
Novel segments. We performed joint de novo genome assembly
by pooling unmapped and discordantly mapped sequence reads
from each family to search genomic segments absent in the
genome reference (GRCh37) (ref. 31). Mapping of the resulting
contigs to the reference genome allowed us to confirm
breakpoints of simple structural variants discovered by
alternative approaches. Some of these alignments are consistent
with more complex variation types, such as large segmental
replacements (Fig. 3, Supplementary Data 3). Contigs that did not
match the genome reference partially or completely were analysed
separately. The size of unmatched sequences ranges from 150 bp
to 133 kb (N50¼ 5.6 kb) spanning 22.2Mb of assembled
sequence. A large proportion of these sequences (14.4Mb)
showed discordance between libraries derived from the same
individual. Homology searches against a non-redundant NCBI
sequence database showed that these segments most likely
represent genomic contaminations (Supplementary Table 3). The
remaining 7.8Mb of sequence (11,350 segments) contained
sequence not represented in genome reference GRCh37. While
the improved GRCh38 assembly places many segments onto the
genome map, 4.3Mb of assembled sequence is still unaccounted
(Supplementary Table 3). These segments represented in part
difficult to assemble repetitive sequence, but also segments thus
far uniquely observed in the Dutch population. Interestingly,
while not matching GRCh38, 11 segments match UniGene
sequences, and include examples of expressed and potentially
functional genes. For example, we identified a novel zinc-finger
(ZNF) gene, harboured within an insertion on chromosome 19
(Fig. 4). Although this novel ZNF gene is absent in the human
reference (both versions GRCh37 and GRCh38), it has close
homology to DNA segments of recently assembled genomes of
non-human primates. Mapping of RNA-seq reads from public
expression data to a modified human reference genome con-
taining the novel segment showed that the inserted segment codes
for a novel spliced ZNF transcript (Fig. 4).
Load and distribution of structural variants. Cluster analysis
was performed to identify genomic hotspots of structural
variants. We confirmed 46 of the 50 deletion hotspots previously
reported32. Furthermore, when additionally considering
duplications, mobile element insertions and inversions 13
variant hotspots were identified, of which 4 have previously not
been described32. Overall each haplotype within the cohort had
on average 758 kb of sequence affected by simple and complex
indels and 4.0Mb by structural variants, amounting to an average
of 4.8Mb of sequence affected by non-SNP variants. On average,
every individual carried 436 kb of homozygous simple and
complex indels and by 2.4Mb of homozygous structural
variants (Table 1, Supplementary Fig. 4).
Rare variants. The majority of small deletions were rare
(with minor allele frequency, MAFo1%, 50.4% of deletions up to
20 bp). Small insertions and mid-sized deletions larger than 20 bp
displayed a higher allele frequency (MAFo1%, 39.7% of
insertions up to 20 bp, and 33.5% of deletions longer than 20 bp)
(Fig. 2, Supplementary Fig. 5). We stratified each deletion, MEI,
short deletion, short insertion and complex indel based on allele
frequencies into quartiles. Significantly more exonic events were
observed in the first quartile for all variant types tested
(Supplementary Data 4). We observed a significant difference in
the distribution of indel events occurring within an OMIM gene.
More specifically, exonic events affecting OMIM disease genes
were more often observed in the first quartile (MAFo0.325%), as
were exonic events involved in a pathway annotated in Kyoto
Encyclopaedia of Genes and Genomes (KEGG) database,
and those in genes when knocked out in mouse resulting in a
phenotype. We observed that rare variants exhibit an excess in
deletions larger than 1 kb in size and AluY insertions. In contrast,
deletions that have large overlap with a SINE/LINE repeat occur
more frequently in the common events quartile (MAF442.5%).
This could also be due to rare mobile element insertions
where the inserted allele has been incorporated in the reference
genome assembly (Supplementary Data 5). These observations
may indicate recent alteration in mutational processes, as
well as differences due to negative selection against large
deleterious variants.
Effect of structural variants on gene expression. We obtained
gene expression data (based on RNA sequencing data generated
from a subset of 115 individuals from the cohort) and tested
the effect of structural variants on gene expression. The effects
of indels, deletions and duplications on gene expression have
been previously described33. We explored effects of inversions
and mobile element insertions on gene expression. Out of 10
inversions and 139 MEIs that overlap exons or core promoters we
found two MEIs with a significant effect on gene expression
(Fig. 5). An AluYa5 insertion was identified in the promoter of
the LCLAT1 gene (Fig. 5a). Samples, which are homozygous
for the AluYa5 insertion display a significantly reduced
expression of the LCLAT1 gene (P¼ 6.87 10 9) (Fig. 5b).
We also identified an AluYb8 element in the last exon of the
ZNF880 gene. This was associated with differential expression of
the last two exons of ZNF880, resulting from alternative splicing
possibly due to effects of the Alu element on RNA secondary
structure (Fig. 5c). These findings show that some of the less
studied types of SV, such as MEIs, can impact gene expression
both quantitatively and qualitatively.
Phasing. We phased all successfully genotyped simple and
complex indels (n¼ 1,792,213) and SVs (n¼ 54,650, excluding
interchromosomal events) (Table 1) with MVNCall25 using the
Affymetrix 6.0 SNP chip based haplotype scaffolds employed for
construction of the reference panel described previously1.
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Linkage disequilibrium between tag SNPs and deletions. To
analyse the extent to which deletions are in linkage disequilibrium
(LD; non-random association between alleles) with SNPs
reported in the NHGRI Catalogue of genome-wide association
studies34 (GWAS), we tested all pairs of GWAS SNPs and
deletions with a distance of at most 1Mb (n¼ 55,250) for being in
LD. Of these pairs, 14,003 (25.3%) showed statistically significant
LD (based on Fisher’s exact test, and controlling false discovery
rate at 5% using with Benjamini-Hochberg’s procedure,
Supplementary Fig. 6). To assess whether this relatively high
percentage of significant associations among the GWAS-SNP
pairs is related to the GWAS status of the SNPs, we performed the
same experiment on similar SNPs (applying a sampling technique
previously described35) that were not associated through GWAS.
We observed a significantly greater number GWAS SNP-deletion
pairs (25.3%) in LD than of non-GWAS SNP-deletion pairs
(19.1%, s.d.¼ 0.2), revealing that deletions deserve attention in
studies of common genetic disorders and might be underlying
some of the current GWAS SNP hits (Supplementary Figs 7
and 8). To test this hypothesis further, we filtered all GWAS
SNP-deletion pairs for those in high LD (r2Z0.8), resulting in
115 pairs (Supplementary Data 6). Among these pairs, an exonic
in-frame deletion (rs148114931) of 9 codons in APOBR appears
twice, linking it to SNP rs151181 which has been associated to
Crohn’s disease36 and SNP rs26528 associated to inflammatory
bowel disease37. Another deletion affected the UTR of ITGA11,
which had been linked to major depressive disorder38. In
addition, 61 intronic deletions were found to be in LD with
SNPs previously associated to disease. In particular, due to the
rigorous FDR correction applied, our catalogue of 115 significant
GWAS SNP-deletion pairs provides strong initial evidence for
further studies (Supplementary Data 6).
Tag SNPs for SVs. We considered SNPs represented on
Affymetrix 6.0 array as well as known GWAS tagSNPs and
compiled a list of SNP-SV pairs exhibiting a high degree of
linkage disequilibrium (r2Z0.8 when considering 8,854 common,
MAF44%, deletions, 3,826 MEIs and 1,024 novel genomic
segments). Beyond 115 deletions described above, other types of
structural variants might be responsible for various human traits.
Thus a total of 76 GWAS SNPs showed high LD (r2Z0.8) with at
least one of 30 polymorphic MEIs or 43 new genomic segments
(Supplementary Data 7). We expect that a significant part of these
SVs might contribute to traits studied by GWAS studies.
Imputing structural variants. Genotype imputation, the
prediction of missing genotypes based on a reference panel, has
been very successful in boosting the power of GWAS, enabling
meta-analyses across individual GWAS studies, and improving
the chances of identifying causal variants by fine-mapping39.
The value of the GoNL panel to robustly impute SNPs and indels
has previously been shown2. We extend this concept and
demonstrate that our SV-integrated panel allows for accurate
imputation of SVs by imputing structural variants in an
independent group of individuals based solely on their SNP
genotype status (see Fig. 6 for a schematic overview). We
genotyped all complex indels, deletions, duplications, inversions,
and MEIs we found (Fig. 6, Step 1) in two independently
sequenced Dutch genomes. We extracted all SVs that could be
genotyped with a confidence of 0.999 (Step 2) in these individuals
to create a set of gold standard genotypes. Gold standard
genotype counts for each SV class are shown in Fig. 7a.
SNP genotypes were filtered to only include those SNPs present
on an Affymetrix 6.0 chip (Step 3), to simulate an array-based
assay. On the basis of SNP genotypes obtained and the GoNL
reference panel we used IMPUTE2 to impute SV genotypes
(Step 4) to compare with the gold standard call. After imputation,
SVs can optionally be filtered based on the genotype likelihoods
(GLs). Here we document the performance for six different
cutoffs (0.33, 0.75, 0.9, 0.95, 0.99 and 0.999). Step 5 thus only
retains genotype calls that meet the respective threshold being
tested. The quality of the remaining imputed genotypes was
Table 1 | Characteristics of the consensus indel and structural variants set.
Type Number Genotyped Validation
rate (%)
Novel
(%)
Rare
(MAF
o1%)
Low freq
(1o¼MAF
o5%)
Common
(MAF4
¼5%)
Mean
Length
Length
Stdev.
Load
(avg. bp/
haplotype)
Load (avg.
homozygous/
genome)
Indel 1,739,300 1,739,300 98 11.5 46.5% 15.5% 38.1% 2.5 2.8 633,765.5 363,862.0
Complex indel 52,913 52,913 80 82.8 25.7% 17.5% 56.8% 9.6 9.0 123,765.9 72,082.9
Deletion 21–100 bp 24,167 22,914 99 21.6 21.5% 14.6% 63.9% 35.9 17.4 230,838.6 160,802.6
Deletion4100 bp 19,840 17,636 93 41.9 49.2% 13.3% 37.5% 3,908.2 21,507.3 3,099,740.4 1,928,806.6
Mobile element insertion 13,469 13,430 96 55.9 54.9% 13.6% 31.6% n/a n/a n/a n/a
Duplication 1,738 601 85 83.9 82.5% 8.2% 9.3% 61,322.2 947,459.0 482,059.4 169,250.2
Inversion 84 69 65 29.8 21.7% 15.9% 62.3% 3,047,390 23,882,994.1 154,510.4 101,262.7
Interchromosomal events 60 46 83 n/a 39.1% 10.9% 50.0% n/a n/a n/a n/a
Novel segments 7,718 n/a 90 n/a n/a n/a n/a 561.3 2,000.8 n/a n/a
Large replacements:
replaced segments
281 n/a 98 n/a n/a n/a n/a 6,053.5 27,970.3 n/a n/a
Large replacements:
replacing segments
281 n/a 98 n/a n/a n/a n/a 1,272.4 2,018.9 n/a n/a
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Figure 2 | Number of simple and complex indels, mobile element
insertions (MEIs) and deletions (stratified by length). Grey bars
correspond to total counts, whereas coloured (blue to violet) bars give
counts stratified into four bins by allele frequency quartiles (Q1 to Q3).
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determined by the fraction of imputed genotypes matching with
the gold standard genotypes (concordance¼ squared correlation;
see Supplementary Information, Section 3.6 for a formal
definition). We refer to its inverse (that is, one minus
concordance) as discordance. The GL threshold influences the
tradeoff between discordance and the fraction of genotypes
missing due to this filter (Fig. 7b). We find that more stringent
filtering leads to an increase in concordance, demonstrating that
the genotype likelihoods are meaningful. Specifically, employing
the most stringent GL filter tested (at a level of 0.999) leads to
only a moderate loss of 8.6–21.6% of genotypes imputed,
depending on the variant type, while the discordance
drops by 83% (from 2.9 to 0.5%) for duplications, by 71%
(from 4.2 to 1.2%) for deletions, by 67% (from 6.9 to 2.3%) for
MEIs, by 42% (from 14.2 to 8.2%) for inversions, and by 38%
(from 10.5 to 6.5%) for complex indels. Based on Fig. 7b, we
consider a threshold of 0.95 (red circle) a good tradeoff and
report these results henceforth. With this setting, only 7.5% of all
SVs are omitted, while the concordance is excellent; 88% for
inversions, 92.4% for complex indels and 96.5% for MEIs, 98% for
deletions and 99.1% for duplications. For the more common SV
classes with more than 1,000 genotype calls (Fig. 7a), namely
complex indels, deletions, and MEIs, we further stratified
performance based on genotypes (Supplementary Fig. 9) and on
allele frequency. We observed that a higher MAF leads towards a
higher discordance in genotypes across all three SV classes
(Fig. 7c). This is driven by the fact that the vast majority of the
rare variants in the GoNL reference panel are not found in these
samples and is thus easy to impute correctly as homozygous
reference. To investigate how well the rare allele could be
imputed, we repeated the analysis restricted to only gold standard
genotypes that contain one copy of the rare allele (that is,
genotypes homozygous for the major allele are discarded), see
Fig. 7d and Supplementary Fig. 10. Only the imputation of rare
SV (or reference) alleles with panel frequencies below 5% leads to
considerable losses in imputation quality, while imputation
performance is excellent for higher MAFs (Supplementary
Fig. 11). Finally, we compared the results of SV imputation
using GoNL and 1,000 Genome Project14 reference panels and a
set of nearly 10,000 of structural variants detected in both
projects. These results showed that SV imputation in two Dutch
individuals using the GoNL panel is more sensitive and specific,
particularly when imputing less frequent alleles (Supplementary
Tables 4 and 5). The percentage of discordant calls was decreased
when imputing with the GoNL panel from 2.7 to 1.2% for
deletions called with a confidence of 0.95 and from 12.9 to 5.5%
for minor allele deletions.
Discussion
The past few years have seen a remarkable progress in human
genome sequencing studies, which has greatly improved our
understanding of human genome variation1,3,13,14,16–18,32.
These projects differ, often substantially, in terms of sample
selection and sequence coverage. For example, to capture global
diversity, the 1,000 Genomes Project selected 2,504 unrelated
individuals from 26 populations and largely relied on the
discoveries from low coverage whole genome data13,14. As a
result a large proportion of common variants with population
frequency greater than 1% have been discovered across multiple
populations. In contrast, the UK10K project combined low
coverage whole-genome with high coverage exome sequencing
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approaches to identify rare variants associated with various
genetic traits17.
We exploit two features of the GoNL study design to create an
SV-integrated reference panel. First, an elevated coverage allows
for enhanced genotyping of SVs18,22,23. Second, the family-based
design aids in establishing haplotypes across significantly longer
ranges than achievable based on unrelated individuals18,19.
Combining these two features yields a wealth of high-quality
SV-integrated haplotypes, which we have corroborated by
imputation experiments. In addition, the family design has
facilitated analysis of variant transmission within a single
generation. We have also been able to compile a list of SVs
that are in high LD with disease associated SNPs which are highly
unlikely to be false discoveries based on additional statistical
analysis.
Our reference panel spans a wide range of variant classes, many
of which have previously not been extensively reported, such as
complex indels and medium-size SVs (affecting between 21 and
100 nucleotides). In particular medium-sized SVs are sometimes
considered a blind spot in short read based variant discovery.
This required method development for both discovery and
genotyping, as well as clean sequencing library protocols.
Furthermore we report a large collection of new genomic
segments, representing several million bases missing from the
genome reference.
Downstream analysis of the variants provided insights into the
mutational dynamics, as well as the consequences of selection
processes affecting structural variants. We show that the
distribution and predicted functional impact of variants differs
significantly between rare and common variants. While
previous studies have demonstrated the effects of polymorphic
deletions on gene expression40, we here identified the effects on
gene expression of additional forms of structural variation such as
MEIs.
The evolution of high-throughput sequencing technologies,
coupled with advances in data analysis, has leveraged substantial
progress in variant detection in next-generation short-read data.
Every new study has fostered our understanding about the human
genome. Nonetheless, there is still considerable room for
improvement26. Difficulties remain in capturing large and
complex structural variants, especially those in repetitive
regions. Evolving third-generation single molecule and long
read sequencing, and further methodological advances such as
global genome map technology, may further improve the
discovery, genotyping and phasing of structural variants. Given
present-generation technology, our approaches and the resulting
reference panel provide both an advanced toolkit and a powerful
resource, with great potential to decisively enhance genome-wide
association and personalized genomics studies.
Methods
Sample collection and data generation. Samples were collected as outlined in
Boomsma et al.19. All participants provided written informed consent, and each
biobank (LifeLines Cohort Study—University Medical Center Groningen, Leiden
Longevity Study—Leiden Universitair Medisch Centrum, Netherlands Twin
Registry—Vrij Universiteit Amsterdam, Rotterdam Study—Erasmus Medical
Center, Rucphen Study—Erasmus Medical Center). Study protocol was approved
by their respective institutional review board (IRB). The whole genome sequencing
using the Illumina HiSeq 2000 platform using 90 bp paired-end reads1. Data were
Het
n = 43
Hom
n = 62
6.0
6.5
7.0
7.5
LC
LA
T1
 
Ex
pr
es
sio
n
P = 6.87e−09
30,450,000 30,550,000 30,650,000
LCLAT1 (+)
Genomic position (bp)
AluYa5
With AluYb8
Without AluYb8
a
b
0
40
80
2
30
22 62
0 5,000 10,000 15,000
0
40
80
1 4
3
3218 42
Ex
pr
es
sio
n
Ex
pr
es
sio
n
bp
c
AluYb8ZNF880
ZNF880 AluYb8
splice
junctions
splice
junctions
Figure 5 | Effects of MEIs on gene expression. (a) Schematic picture indicating an AluYa5 insertion in the promoter region of LCLAT1. (b) LCLAT1 gene
expression (log2 of normalized read count) in blood from GoNL individuals who are heterozygous (het) or homozygous (hom) for the AluYa5 insertion.
(c) RNA expression effects of an AluYb8 insertion in the last exon of ZNF880. The presence of the AluYb8 element results in spliced transcripts, which
preferentially contain the last exon, while the before last exon is skipped (upper panel). The reverse effect is seen in the absence of the AluYb8 insertion
(lower panel).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12989 ARTICLE
NATURE COMMUNICATIONS | 7:12989 | DOI: 10.1038/ncomms12989 | www.nature.com/naturecommunications 7
mapped to the UCSC human reference genome build 37 using BWA 0.5.9-r16 and
quality control was performed as described earlier1.
Structural variation discovery. We used 12 different algorithms for the discovery
of structural variants, which use four different general approaches: split-read
mapping, (discordant) read pairs, read depth, de novo assembly and combinations
thereof, as shown in Fig. 1a. Details about how the individual methods were run are
provided in Supplementary Information.
Generation of consensus call set. After creation of the algorithm specific calls
sets a consensus set of indels and SVs were made for each to the SV types (indels,
deletions, insertions, duplications, inversions, interchromosomal events and mobile
element insertions). Events were merged per variant type using an algorithm-aware
merging strategy (Supplementary Table 1). A consensus region was defined when
overlapping regions were identified by 2 different detection strategies (for example
split read and discordant read pair, see Supplementary Fig. 5 for the contributions
of individual strategies for deletion detection, stratified by AF and event length),
and the boundaries of the event were determined by the algorithm with the highest
breakpoint accuracy (as determined by the calling strategy) in combination with a
50% reciprocal overlap. For variants 20 bp and smaller in size an exact overlap was
used, with support from at least two different methods.
Validation experiments. Validation was performed using PCR amplification of
breakpoint junctions, and subsequent sequencing of the PCR products via Sanger
or MiSeq sequencing. The validation set consisted of at least 96 candidates for
indels, mid-size deletions, large deletions, MEIs, large replacements and novel
segments, as well as 48 duplications, 76 inversions, 42 interchromosomal
breakpoints and 10 complex indels (see Supplementary Data 1).
Genotyping and phasing. To genotype SVs, we used GATK’s HaplotypeCaller for
complex indels, MATE-CLEVER for deletions, Mobster for MEIs and Delly for
inversions, duplications, and translocations. Details on how each tool was run are
collected in Supplementary Information. For phasing, we used the haplotype
scaffolds described earlier1 to phase SVs onto the already phased sets of SNPs and
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indels. The scaffold contains sites present on Affymetrix SNP 6.0 chips. Refer to the
supplement of our previous study1, Section 12, for details on how it was created.
Phasing was done using MVNcall version 1.1 (ref. 25). We used the genotype
likelihoods (GLs) reported by the genotyping tools described above. Before
phasing, the GLs were regularized so as to avoid too low probabilities as detailed in
the Supplementary Information.
GWAS SNP permutation test. For every GWAS SNP-deletion pair, we randomly
selected a non-GWAS SNP-deletion pair that was similar in terms of potentially
confounding variables, see Supplementary Information for those variables. We
then applied Fisher’s exact test and the Benjamini–Hochberg FDR control proce-
dure on the matched non-GWAS SNP-deletion set and recorded the percentage of
statistically significant pairs. This sampling procedure was repeated 1,000 times.
The samples were found to have a mean of 19.1% and s.d. of 0.20, against the
percentage of 25.3% for the GWAS SNPs (Supplementary Fig. 8), see
Supplementary Information, Section 3.4, for further details.
Imputation of structural variants. SV genotyping of two independent Dutch
individuals was done using the same pipeline as for genotyping SVs in the GoNL
panel (see Supplementary Information), that is, GATK/HaplotypeCaller was used
for complex indels, MATE-CLEVER for deletions, DELLY for duplications and
inversions, and Mobster for MEIs. Genotype likelihoods (GLs) provided by these
tools were used to determine the gold standard set, requiring a probability of 0.999
of the genotype being correct for all call types except for MEIs, where we used 0.85
account for differently calibrated GLs. For imputation of SV genotypes based on
SNP genotypes and the GoNL panel, we used IMPUTE2 (ref. 41). Therefore, we
first used SHAPEIT2 (ref. 42) for first phasing all SVs with the SNPs using the
GoNL panel. Refer to Supplementary Information, Section 3.6 for the details such
as command line arguments. Note that phasing genetic variants using SHAPEIT2
before imputing genotypes with IMPUTE2 follows best-practice recommendations
(see IMPUTE2 https://mathgen.stats.ox.ac.uk/impute/impute_v2.html). The
expected discordance between true and imputed genotype is based on comparing
the probability distribution over the three different genotypes provided by
IMPUTE2 for the imputed genotypes on the one hand, and the probability dis-
tribution provided by the read-based genotyping tools on the other hand, see
Supplementary Information, Section 3.6 for details and definitions. We refer to the
expected value of the discordance just as ‘discordance’ in the main text and we refer
to 1-discordance as concordance.
Data availability. The references to depositories of software packages and para-
meters used in each analysis are given within corresponding sections of
Supplementary Note. Sequence data have been deposited at the European Genome-
phenome Archive (EGA), which is hosted by the European Bioinformatics Institute
(EBI), under accession number EGAS00001000644, as well as genotyped variants
discovered in this study, accession number EGAD00001002261. All variants calls,
their allele frequencies and novel sequences are available from the official con-
sortium webpage: http://www.nlgenome.nl. All other data are available from the
corresponding authors on request.
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